Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Le, Diem
NCT03520075 / 2018-004568-72: Study of ASTX029 in Subjects With Advanced Solid Tumors	Active, not recruiting	1/2	190	Europe, US	ASTX029	Taiho Oncology, Inc.	Solid Tumor, Adult	08/24	12/25
NCT04774952: Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors	Active, not recruiting	1	108	US	RMC-5552	Revolution Medicines, Inc.	Solid Tumors	03/24	03/24